In glioma, T cell immunotherapies are limited by the quantity of available T cells. @kiritsingh.bsky.social & team address this challenge in preclinical models by peripheral injection of autologous T cells after pre-treatment with IL-7. Full report buff.ly/gslmMgl

LOOK WHAT MY FRIEND @kiritsingh.bsky.social SPOTTED IN NORTH CAROLINA YESTERDAY. WHAT! #GTFC who is this and how can we be friends?